BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2183156)

  • 1. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
    Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
    Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas.
    Wang LC; Vass W; Gao CL; Chang KS
    Cancer Res; 1987 Aug; 47(15):4192-8. PubMed ID: 2886216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic changes in human male germ cell tumors.
    Lothe RA; Peltomäki P; Tommerup N; Fosså SD; Stenwig AE; Børresen AL; Nesland JM
    Lab Invest; 1995 Nov; 73(5):606-14. PubMed ID: 7474934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular oncogenes in human teratocarcinoma cell lines.
    Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
    Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of ras gene mutations and methylation state in human leukemias.
    Browett PJ; Norton JD
    Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
    Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA
    Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated ras genes in human seminoma: evidence for tumor heterogeneity.
    Mulder MP; Keijzer W; Verkerk A; Boot AJ; Prins ME; Splinter TA; Bos JL
    Oncogene; 1989 Nov; 4(11):1345-51. PubMed ID: 2682461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
    Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
    Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T
    Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MNU-induced point mutation and activation of c-Ha-ras oncogene in cell lines derived from human pancreas explants.
    Maheshwari KK; Parsa I; Marsh WH
    Biochem Int; 1990; 20(1):117-25. PubMed ID: 2183801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
    Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
    Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proto-oncogene amplification and overexpression in cadmium-induced cell transformation.
    Spruill MD; Song B; Whong WZ; Ong T
    J Toxicol Environ Health A; 2002 Dec; 65(24):2131-44. PubMed ID: 12515591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods in laboratory investigation. Rapid and simple detection of c-Ki-ras2 gene codon 12 mutations by nonradioisotopic single-strand conformation polymorphism analysis.
    Sugano K; Kyogoku A; Fukayama N; Ohkura H; Shimosato Y; Sekiya T; Hayashi K
    Lab Invest; 1993 Mar; 68(3):361-6. PubMed ID: 8450652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification and activation of c-Ki-ras oncogene in cell line developed from human pancreas explants.
    Maheshwari KK; Parsa I
    Biochem Int; 1991 Sep; 25(2):233-40. PubMed ID: 1789790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant testicular tumors: cytogenetic and molecular biology principles].
    Strohmeyer T
    Urologe A; 1993 May; 32(3):201-6. PubMed ID: 8511833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
    Ponzetto C; Giordano S; Peverali F; Della Valle G; Abate ML; Vaula G; Comoglio PM
    Oncogene; 1991 Apr; 6(4):553-9. PubMed ID: 1674365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines.
    Vilette D; Emanoil-Ravier R; Buffe D; Rimbaut C; Peries J
    Cancer Res; 1987 Feb; 47(3):867-73. PubMed ID: 3542196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.